Vuu, Irene http://orcid.org/0000-0001-8580-2835
Wahlstrom, Jan http://orcid.org/0000-0002-9434-1302
Houk, Brett E. http://orcid.org/0000-0002-1979-917X
Article History
Accepted: 14 November 2022
First Online: 18 December 2022
Declarations
:
: The studies included in this article and the analyses reported were funded by Amgen Inc., Thousand Oaks, CA, USA.
: All authors are employees and stockholders of Amgen Inc.
: The study followed the ethical principles of the Declaration of Helsinki, the International Conference on Harmonization Guideline for Good Clinical Practice, and local regulations (US Code of Federal Regulations Title 21). The protocol, informed consent, and amendments were approved by the Institutional Review Board (Salus Institutional Review Board, Austin, TX, USA).
: Written informed consent was provided prior to enrollment by all subjects.
: Not appplicable.
: Qualified researchers may request data from Amgen clinical studies. Complete details are available at the following: ExternalRef removed.
: Not appplicable.
: All authors contributed to the study conception and design. The first draft of the manuscript was written by IV and JW and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.